Lipid nanoparticles (LNPs) act as carriers for mRNA and CRISPR payloads across a wide range of therapeutic applications, from cancer to inflammatory and genetic diseases. The same delivery system used ...
Engineers at the University of Pennsylvania have developed LIBRIS, an automated microfluidic platform that dramatically ...
Full Circles Therapeutics today announced that its circular single-stranded DNA (cssDNA, C4DNAtm) technology platform has been highlighted as a key enabling component of a new genome engineering ...
Lipid nanoparticles, or LNPs, are best known as the delivery system used in the COVID-19 mRNA vaccines given to billions of people worldwide. Scientists are now exploring their potential far beyond ...
2d
Simple 'cocktail' of amino acids dramatically boosts power of mRNA therapies and CRISPR gene editing
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...
Explore the future of gene therapy delivery with lipid nanoparticles. Learn how they can transform treatments for various diseases.
Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...
4dOpinion
Bugs Inside Them.
On a typical day, they greet farmers bringing them ticks, real estate agents with mysterious roaches and anxious homeowners ...
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution.
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center ...
Taner, M.D., Ph.D., who leads Mayo Clinic's Precision Medicine in Neurodegeneration Lab, studies complex genetic interactions in Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results